FDA Transition for Medical Devices Marketed Under EUA or an Enforcement Policy During the COVID-19 Pandemic
Published Nov 6, 2023
Summary
CBP relays FDA guidance on the phased transition for medical devices previously marketed under COVID-19 enforcement policies or EUAs, detailing which Intended Use Codes and Affirmation of Compliance information filers should transmit at entry as Phase 3 begins November 7, 2023.
Summary is machine-generated at the linking layer for discovery only. Refer to the source bulletin for authoritative guidance.
CSMS 58306521 · full bulletinRelated bulletins
Consumer Product Safety Commission (CPSC) Implementation Guide and Partner Government Agency (PGA) Flag Enforcement Table Documents Updated on CBP.gov
Jul 28, 2026
Harmonized System Update (HSU) 2617
Jul 27, 2026
Harmonized System Update (HSU) 2616
Jul 23, 2026
Notice from the U.S. Fish and Wildlife Service regarding Final Rule Amending 50 CFR Part 10 Shellfish Definition and Updated Tariff Flagging
Jul 15, 2026
Harmonized System Update (HSU) 2615
Jul 14, 2026